Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases (Q3696479): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Introduction of chronic preventive treatment based on oral administration of S-nitrosothiols (RSNO), translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases | |||
Revision as of 10:39, 22 November 2021
Project Q3696479 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases |
Project Q3696479 in France |
Statements
15,500.0 Euro
0 references
32,000.0 Euro
0 references
48.44 percent
0 references
1 September 2015
0 references
31 December 2016
0 references
Université de Lorraine
0 references
Mise en place d’un traitement chronique préventif, basé sur l’administration orale de S-nitrosothiols (RSNO (French)
0 references
Introduction of chronic preventive treatment based on oral administration of S-nitrosothiols (RSNO) (English)
22 November 2021
0 references
Identifiers
LO0006484
0 references